Insertable cardiac monitor with a long sensing vector: Impact of obesity on sensing quality and safety.
Giovanni Bisignani, Silvana De Bonis, Bertrand Pierre...
https://pubmed.ncbi.nlm.nih.gov/37025684/Actively Recruiting
Led by Biotronik SE & Co. KG · Updated on 2025-10-01
1400
Participants Needed
31
Research Sites
13 weeks
Total Duration
This research aims to evaluate the long-term outcomes, performance, and ongoing safety of the BIOMONITOR III and its possible successors in everyday clinical use. It focuses on patients with conditions such as tachycardia, atrial fibrillation, syncope, bradycardia, or cryptogenic stroke. The study is designed as an observational registry, allowing additional scientific investigations with minimal extra effort for participants and study sites. Participants will receive a BIOTRONIK Implantable Cardiac Monitor ICM and will use the CardioMessenger device to support the BIOTRONIK Home Monitoring system. The registry monitors patients under routine clinical care without introducing experimental treatments or interventions. Data collection includes the insertion procedure and success rate of the device, as well as the time taken to reach a relevant diagnosis starting from device implantation. Throughout the study, participants will be observed during their regular clinical care visits. Researchers will collect information on device performance, safety, and diagnostic timelines. The study will continue until August 30, 2027, tracking patient outcomes over this extended period. Participation involves consenting to the use of home monitoring technology and agreeing to data collection related to the implanted device and clinical events.
CONDITIONS
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
S
Sabrina Hoche, Dr.
D
Dörte Vossmeyer, Dr.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Biotronik SE & Co. KG
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of insertion
Participants receive the BIOTRONIK Implantable Cardiac Monitor device as part of routine clinical care.
1 visit (in-person)
Duration - Up to 5 years
Participants who undergo routine care are observed through the BIOTRONIK Home Monitoring system to track clinical outcomes and device performance.
Ongoing remote monitoring with periodic in-person follow-ups as part of routine care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Giovanni Bisignani, Silvana De Bonis, Bertrand Pierre...
https://pubmed.ncbi.nlm.nih.gov/37025684/Biotronik SE & Co. KG
Lead Sponsor